Enhancing a Free Hematology/Oncology Drug Knowledgebase
Official title: Enhancing the HemOnc Knowledgebase of Chemotherapy Drugs and Regimens
Funded at Rhode Island Hospital · NIH-11397698 · Data updated 2026-11-12
A project to expand and improve HemOnc.org, a free online resource with detailed information about cancer drugs and regimens for clinicians and researchers.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rhode Island Hospital NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project start | September 15, 2022 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $671,944 |
| NIH project number | 5U24CA265879-05 |
| Project ID | NIH-11397698 on NIH RePORTER |
Who could benefit from this research
✓Could help
Clinicians, pharmacists, researchers, and translational scientists who treat or study cancer patients and rely on up-to-date drug regimens and guidelines.
✕Less likely to help
Direct patient participation is not required for this knowledgebase-focused work, so some patients may not interact with the platform.
What this research studies
This grant supports expanding HemOnc.org, a large, freely accessible database of anti-cancer drugs, regimens, and guidelines used by clinicians, pharmacists, and researchers. The team will enhance structure, vocabulary, and interoperability with standards like RxNorm, SNOMED-CT, and OncoTree to improve searchability and data accuracy. The effort aims to help patients receive safer, more effective treatments by making up-to-date, evidence-based information more accessible to healthcare professionals who guide care. It also enables translational research and collaboration by linking to projects like AACR GENIE and DeepPhe. The work is patient-facing in that it directly supports clinical decision-making and could influence treatment choices through better knowledge sharing.
Why it matters
Potential benefit: If successful, it could improve the accuracy and speed of cancer treatment decisions, potentially enhancing patient outcomes and safety.
How similar studies have gone: Similar knowledgebases and standardized vocabularies have shown value in improving clinical decision-making and research collaboration.
Where this research is happening
-
Rhode Island Hospital
Providence, United States Active
Researchers
- Principal investigator: Warner, Jeremy L — Rhode Island Hospital
- Study coordinator: Warner, Jeremy L
Related research
Other NIH-funded projects on the same topics.
-
Photodynamic lipids to boost chemotherapy for metastatic ovarian cancer
A patient-friendly approach tests a light-activated method to make ovarian cancer metastases more sensitive to chemotherapy.
-
Dual targeting of heart cell receptors to prevent chemotherapy heart damage
Atrial patients receiving the chemotherapy drug doxorubicin may be protected from heart damage by targeting two heart cell receptors at once.
-
A 3D ultrasound scanner to see early chemotherapy response in breast cancer
A new 3D ultrasound imaging method will be tested to see if it can quickly show whether breast cancer is responding to chemotherapy.
-
Non-invasive, microscopic biomarkers to detect CIPN in chemotherapy patients
This grant aims to develop a non-invasive imaging method to measure nerve changes in patients undergoing chemotherapy to better understand and monitor chemotherapy-induced peripheral neuropathy (CIPN).
-
Alternative NF-kB activation after chemotherapy in ovarian cancer
This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.
-
Genetic clues for doxorubicin heart risk using patient-derived heart cells
A research project tests how human heart cells grown from stem cells react to a common chemotherapy to see which genetic differences may raise the risk of heart damage.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.